Robotic Enhanced Error Training of Upper Limb Function in Post-stroke Patients
Launched by REUTH REHABILITATION HOSPITAL · Dec 13, 2021
Trial Information
Current as of June 17, 2025
Unknown status
Keywords
ClinConnect Summary
Background: At least 85% of stroke survivors suffer from weakness in their upper limbs. Around 40% of stroke survivors will suffer from severe handicap in their paretic arm, negatively affecting their independence and quality of life. Only 30% - 70% of survivors will recover enough function to enable daily use of the arm. These numbers clearly indicate that despite significant advances in the ability to rehabilitate stroke patients, there is still a need for more effective methods.
Traditional rehabilitative methods to improve arm function after stroke are often time-consuming and labor-in...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hebrew speaker.
- • First stroke (ischemic or hemorrhagic).
- • Weakness on one side of the body (left or right).
- • At least 21 days have passed since the stroke event.
- • At least 21 days left for inpatient rehabilitative care.
- • Have partial mobility in the elbow and shoulder and the ability to open and close the hand.
- • A minimum score of 10 (out of the 66) on the Fugl-Meyer Assessment for the upper limb.
- • Cognitive status: Mini-Mental State Examination \[MMSE\] = 23 or higher; or MoCA test = 26 or higher.
- Exclusion Criteria:
- • Complete paralysis of the affected side.
- • Comorbid central nervous system diseases that may affect brain plasticity (MS, ALS).
- • Sensory Aphasia (as per the medical diagnosis).
- • One-side neglect.
- • Apraxia.
- • Pregnancy or breastfeeding.
- • Strong pain in the shoulder (VAS\>6) that may prevent the ability to execute the tasks
- • A severe orthopedic problem in the upper limb that prevents the ability to execute tasks on the robotic system.
About Reuth Rehabilitation Hospital
Reuth Rehabilitation Hospital is a leading healthcare institution specializing in advanced rehabilitation services and innovative clinical research aimed at enhancing patient outcomes. With a commitment to excellence in patient care, Reuth integrates cutting-edge medical practices and evidence-based approaches to support individuals recovering from various conditions. The hospital actively sponsors clinical trials that focus on rehabilitation techniques, therapeutic interventions, and health technologies, fostering collaboration with academic and research institutions to drive advancements in the field. Through its dedication to research and patient-centered care, Reuth Rehabilitation Hospital plays a pivotal role in shaping the future of rehabilitation medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
Patients applied
Trial Officials
Rami Mansour, MD
Principal Investigator
Reuth Rehabilitation Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials